Gumintad, Maximo B.

HRN: 11-94-20  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/22/2026
05/28/2026
IV
500mg
Q8H
Amoebiasis
Checking Initial Appropriateness 
05/25/2026
METRONIDAZOLE 500MG (TAB)
05/25/2026
05/30/2026
PO
750
Q8
Amoebiasis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: